Over 25 years of experience and expertise in clinical research in the U.S. and China
Oversaw a 21,000-patient ‘megatrial’ for Lovenox (enoxaparin) resulted in its successful global registration
Built the Asia Pacific regional R&D function of 1,400 staff members encompassing Japan, reporting directly to Global R&D
M.D. from Nanjing Medical University in China, Ph.D. in Immunology from the University of British Columbia in Canada, Internal Medicine Residency and postdoctoral fellowship at Washington University School of Medicine, certified physician in the U.S. by the Educational Commission for Foreign Medical Graduates.
A seasoned leader with a proven track record of over 26 years working at leading multinational pharmaceutical companies; 10 years of Country Manager experience at Bristol-Myers Squibb (BMS), Allergan, and Genzyme in China; built Allergan China operation from a small base to the second largest globally;
Led successful launches of numerous brands and established them as market leaders in China, including Opdivo®, Botox®, Alimta®, Gemzar®, Taxol® and Juvederm®;
Devoted 15 years to the oncology field as VP & Head of Oncology BU, Eli Lilly China, and as Head of Marketing, Oncology at BMS China;
Started her career as an OB-GYN Doctor and got her M.D. degree from Tongji University School of Medicine in China; received her MBA from the University of Leicester, United Kingdom.
A physician scientist and senior executive with 25+ year biomedical research and biopharmaceutical R&D experience in oncology, form discovery, translational medicine to clinical development;
Served as SVP and Head of Clinical Development at BeiGene, built BeiGene's clinical team and led the clinical development of 4 oncology assets from Phase I to pivotal trials including the first China-developed anti-PD-1 mAb；
Led the research and development of over 10 oncology assets while serving as Oncology Medical Director at Covance (U.S.), Senior Principal Scientist in cancer translational medicine at Pfizer (U.S.) and Research Scientist in cancer genomics at Tularik/Amgen (U.S.);
Ph.D. from UT Southwestern Medical Center; postdoctoral fellowship at Harvard University; M.D. from Hubei Medical College.
Over 20 years of experience in global oncology development and scientific research;
Executive Director of Oncology Early Development at Merck(MSD) where he oversaw the development of 10+ oncology products from preclinical to proof-of-concept stage;
Leader of the Oncology Team of Excellence for Strategy in Therapeutic Area at Daiichi-Sankyo where he led Phase III trial for pexidartinib;
Faculty as Assistant Member at Memorial Sloan-Kettering Cancer Center and Assistant Professor at Weill Cornell Medical School;
M.D and Ph.D. in Biochemistry & Molecular Biology from the University of Southern California; fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center and board-certified medical oncologist.
Life Science technology professional with over 20 years' experience；
General Manager at BSK BIO of Simcere. Manager Principal Scientist at Roche(US). Senior Scientist at Biospecifics Technologics(US)；
One launched biologics, five launched Companion Diagnostics and eleven IND approvals. Led team manufacture billion-dollar value products;
BS and PhD from China Pharmaceutical University, Post-doctoral from Mount Sinai School of Medicine; NMPA-appointed expert for Institute of Executive Development Training.
Over 25 years of experience gained in primary health care institutions, within the former China Food and Drug Administration (CFDA), and at medical device and internet companies;
Served as Chief Food Safety Officer at Alibaba Group's Ele.me, and Deputy General Manager of Public Affairs at Shenzhen Mindray Biomedical Electronics Co., Ltd.;
Served at the CFDA as the Director of the Development Planning Department , the Deputy Director of the General Office, the Assistant Director of the Emergency Management Department, and the Deputy Inspector of the Food Safety Supervision Department;
Deputy Director of the Health Bureau of Fengtai District in Beijing, and has over 10 years of experience in the public health field;
Master's degree in Public Health from Hebei Medical University, bachelor's degree in Preventive Medicine from Capital Medical University. Selected by the Bureau of Foreign Expert Affairs for an education program at Duke University for Public Policy, and also by the U.S. Government for the Humphrey Scholars program in Public Health at Emory University.